$FEMY 3 SEC Filings

Filed On	Filing
11 Aug 2026	Form 3: Mifek Jeffrey Gerald, Chief Clinical-Medical Affairs Holds 1,411 shares of Common Stock
01 Apr 2026	Form 3: Canning John Charles, Chief Operating Officer Holds 30,000 shares of Common Stock
24 Mar 2026	Form 3: Eichenbaum Kenneth D., Director Holds 25,010 shares of Common Stock
17 Feb 2026	Form 3: Sipos Jeremy Alexander, Chief Technology Officer Holds 46,278 shares of Common Stock
01 Jul 2025	Form 3: Nicholas Kelley Stinson, Chief Commercial Officer Holds 80 shares of Common Stock
13 Feb 2024	Form 3: Spector Richard D., Chief Commercial Officer No securities owned
28 Nov 2023	Form 3: PharmaCyte Biotech, Inc., 10% owner
22 Nov 2023	Form 3: Silverman Joshua, Director No securities owned
16 Jun 2023	Form 3: Milnes Alistair, Director No securities owned
16 Jun 2023	Form 3: Kendall Keith J, Director No securities owned
17 Oct 2022	Form 3: Thomas Christine E, SVP, Regulatory & Clinical No securities owned
01 Mar 2022	Form 3: Elefant Dov, Chief Financial Officer No securities owned
20 Jan 2022	Form 3: Perrow Wendy, Director No securities owned
09 Sep 2021	Form 3: Evantash Edward, Chief Medical Officer No securities owned
17 Jun 2021	Form 3: Morrissey Anne, Director No securities owned
17 Jun 2021	Form 3: Witte William Benson, Director
17 Jun 2021	Form 3: Lee-Sepsick Kathy, Director Holds 277,778 shares of Common Stock
17 Jun 2021	Form 3: Dyett John, Director
17 Jun 2021	Form 3: Larsen Charles, Director
17 Jun 2021	Form 3: Uzialko Edward R, Director Holds 27,786 shares of Common Stock

Comments